AROMHA Brain Health Test: A Remote Olfactory Assessment as a Screen for Cognitive Impairment

Benoit Jobin,Colin Magdamo,Daniela Delphus,Andreas Runde,Sean Reineke,Alysa Alejandro Soto,Beyzanur Ergun,Alefiya Dhilla Albers,Mark W Albers
DOI: https://doi.org/10.1101/2024.08.03.24311283
2024-08-06
Abstract:Cost-effective, noninvasive screening methods for preclinical Alzheimer's disease (AD) and other neurocognitive disorders remain an unmet need. The olfactory neural circuits develop AD pathological changes prior to symptom onset. To probe these vulnerable circuits, we developed the digital remote AROMHA Brain Health Test (ABHT), an at-home odor identification, discrimination, memory, and intensity assessment. The ABHT was self-administered among cognitively normal (CN) English and Spanish speakers (n=127), participants with subjective cognitive complaints (SCC; n=34), and mild cognitive impairment (MCI; n=19). Self-administered tests took place remotely at home under unobserved (among interested CN participants) and observed modalities (CN, SCC, and MCI), as well as in-person with a research assistant present (CN, SCC, and MCI). Olfactory performance was similar across observed and unobserved remote self-administration and between English and Spanish speakers. Odor memory, identification, and discrimination scores decreased with age, and olfactory identification and discrimination were lower in the MCI group compared to CN and SCC groups, independent of age, sex, and education. The ABHT revealed age-related olfactory decline, and discriminated CN older adults from those with cognitive impairment. Replication of our results in other populations would support the use of the ABHT to identify and monitor individuals at risk for developing dementia. Keywords: Remote assessment, screening, Alzheimer's disease, Mild cognitive impairment, olfaction.
Neurology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to develop a cost - effective and non - invasive screening method for the early identification of Alzheimer's disease (AD) and other neurocognitive disorders. Specifically, the research team has developed a remote digital olfactory assessment tool named AROMHA Brain Health Test (ABHT), aiming to assess olfactory function through home - self - testing, thereby screening for the risk of cognitive impairment. ### Main problems 1. **Developing effective screening tools**: Currently, there is a lack of effective, low - cost, non - invasive screening methods for the early identification of Alzheimer's disease and other neurocognitive disorders. 2. **The relationship between olfaction and cognitive impairment**: The olfactory neural circuit may be affected by the pathological changes of Alzheimer's disease before symptoms appear, so the olfactory test can be used as a potential early screening method. 3. **The feasibility of remote self - testing**: Verify the reliability and validity of ABHT under different conditions (such as remote self - testing under observation and remote self - testing without observation), and its applicability in different language backgrounds. 4. **Distinguishing individuals with different cognitive states**: Evaluate whether ABHT can effectively distinguish individuals with normal cognition (CN), subjective cognitive complaints (SCC), and mild cognitive impairment (MCI). ### Research objectives 1. **Verify the effectiveness of remote self - testing**: Compare the results of remote self - testing without observation and remote self - testing with observation, and verify the reliability of ABHT under different conditions. 2. **Evaluate the applicability in different language backgrounds**: Compare the performance of English and Spanish speakers in ABHT and verify its applicability in different language groups. 3. **Evaluate the relationship between olfactory function and age**: Analyze the influence of age on olfactory function, especially the influence on the olfactory performance of individuals with different cognitive states. 4. **Distinguishing individuals with different cognitive states**: Evaluate whether ABHT can effectively distinguish individuals with normal cognition, subjective cognitive complaints, and mild cognitive impairment. Through these objectives, the research team hopes to provide a new and convenient method for the early identification and monitoring of Alzheimer's disease and other neurocognitive disorders.